ClinicalTrials.Veeva

Menu

Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population.

M

Max Healthcare

Status

Completed

Conditions

Solid Tumor

Study type

Observational

Funder types

Other

Identifiers

NCT06456216
MOI-PAN-2022

Details and patient eligibility

About

Performance evaluation of diagnostic accuracy (Sensitivity and Specificity) of PanTum detect Test for detection of solid tumours in known cancer population (Sick population) and in cancer free (Healthy) population.

Full description

PanTum Detect is a simple blood test that can detect presence of solid tumors using two important tumor biomarkers - Apo 10 and TKTL-1. Most tumors develop slowly and gradually. From the first tumor cell, to the identification of the tumor itself, there can be a timespan of many years. The turning point where a locally growing tumor develops into an invasive, metastasizing cancer is paramount for curability. It is the objective of PanTum Detect to detect a tumor in time before this critical turning point. Such locally growing tumors can often easily be removed by surgery or treated successfully

Enrollment

90 patients

Sex

All

Ages

30 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. written informed consent
  2. sick population with hiostopathology proven diagnosis
  3. age 30-75 years
  4. newly diagnosed case of solid tumor.

Exclusion criteria

  1. history of past surgery within 8 weeks.
  2. history of any chemotherapy, vaccination etc

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems